Department of Surgery, Campus Benjamin Franklin, Charité University Medicine, Hindenburgdamm 30, 12200, Berlin, Germany.
Department of Surgery, Rotes Kreuz Krankenhaus, Bremen, Germany.
J Gastrointest Surg. 2018 Jan;22(1):146-153. doi: 10.1007/s11605-017-3568-x. Epub 2017 Sep 12.
The accuracy of pretherapeutic staging of lymph nodes (LN) in rectal cancer by MR imaging (MRI) is still limited. The aim of the study was to determine the sensitivity and specificity of different morphological criteria in nodal staging.
LN were analyzed by MRI in 60 patients with rectal cancer and primary surgery. Signs of LN metastasis (cN+) were spiculated/indistinct border contour, inhomogeneous signal intensity, or LN size. The accuracy of these signs for clinical LN staging was analyzed with conclusive postoperative histological lymph node examination.
68.3% of patients with nodal metastasis (pN+) were correctly identified by size with a cutoff value of 7.2 mm. This, however, was not inferior to the 76.7% identified using the inhomogeneous morphological signal intensity and spiculated/indistinct border contour criteria (p = 0.096). 3.3 versus 5% were overstaged, and 28.3 versus 18.3% understaged by these criteria. Sensitivities/specificities for (a) size, (b) spiculated/indistinct border contour, and (c) inhomogeneous signal intensity and spiculated/indistinct border contour were (a) 32%/94%, (b) 56%/86%, and (c) 56%/91%, respectively.
The accuracy of LN staging in rectal cancer was not improved by morphological criteria. These limitations suggest being reticent when recommending neoadjuvant chemoradiation merely based on preoperative positive LN staging.
磁共振成像(MRI)对直肠癌淋巴结(LN)的术前分期准确性仍有限。本研究旨在确定不同形态学标准在淋巴结分期中的敏感性和特异性。
对 60 例直肠癌患者行 MRI 检查,并进行了原发手术。LN 转移的征象(cN+)包括分叶状/模糊边界轮廓、信号强度不均匀或 LN 大小。分析这些征象对临床 LN 分期的准确性,以明确术后组织学淋巴结检查的结果。
有 68.3%的淋巴结转移(pN+)患者的大小(截断值为 7.2mm)可正确识别。然而,这并不优于使用信号强度不均匀和分叶状/模糊边界轮廓标准的 76.7%(p=0.096)。这些标准分别有 3.3%和 5%的患者过度分期,28.3%和 18.3%的患者分期不足。(a)大小、(b)分叶状/模糊边界轮廓和(c)信号强度不均匀和分叶状/模糊边界轮廓的敏感性/特异性分别为(a)32%/94%、(b)56%/86%和(c)56%/91%。
形态学标准并不能提高 LN 分期的准确性。这些局限性提示,在仅仅基于术前阳性 LN 分期推荐新辅助放化疗时应持谨慎态度。